Shattuck Labs, Inc. Basic Shares Outstanding (Weighted Average)
Shattuck Labs, Inc. (STTK) reported Basic Shares Outstanding (Weighted Average) of 129.78 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- Shattuck Labs, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 129.78M shares, a 154.46% increase year-over-year.
- Shattuck Labs, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 112.23M shares, a 120.22% increase year-over-year.
- Shattuck Labs, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 104.03M shares, a 104.62% increase year-over-year.
- Shattuck Labs, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 72.18M shares, a 42.00% increase year-over-year.
- Shattuck Labs, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 69.58M shares, a 37.09% increase from fiscal 2024.
- Shattuck Labs, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 50.76M shares, a 19.15% increase from fiscal 2023.
- Shattuck Labs, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 42.60M shares, a 0.52% increase from fiscal 2022.
- Shattuck Labs, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 42.38M shares, a 0.82% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 129.78M shares 10-Q · filed 2026-08-11 | 121.68M shares 10-Q · filed 2026-08-11 | 115.35M shares derived: average of 3 quarters · filed 2026-08-11 | 104.56M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 112.23M shares 10-Q · filed 2026-05-07 | 108.13M shares derived: average of 2 quarters · filed 2026-05-07 | 96.15M shares derived: average of 3 quarters · filed 2026-05-07 | 84.86M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | 104.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 88.11M shares derived: average of 2 quarters · filed 2026-03-05 | 75.74M shares derived: average of 3 quarters · filed 2026-08-11 | 69.58M shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 72.18M shares 10-Q · filed 2025-11-06 | 61.59M shares derived: average of 2 quarters · filed 2026-08-11 | 58.10M shares 10-Q · filed 2025-11-06 | 56.25M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | 51.00M shares 10-Q · filed 2026-08-11 | 50.98M shares 10-Q · filed 2026-08-11 | 50.94M shares derived: average of 3 quarters · filed 2026-08-11 | 50.91M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 50.97M shares 10-Q · filed 2026-05-07 | 50.90M shares derived: average of 2 quarters · filed 2026-05-07 | 50.88M shares derived: average of 3 quarters · filed 2026-05-07 | 50.86M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 50.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 50.84M shares derived: average of 2 quarters · filed 2026-03-05 | 50.82M shares derived: average of 3 quarters · filed 2026-03-05 | 50.76M shares 10-K · filed 2026-03-05 |
| 2024-09-30 | 50.83M shares 10-Q · filed 2025-11-06 | 50.81M shares derived: average of 2 quarters · filed 2025-11-06 | 50.73M shares 10-Q · filed 2025-11-06 | 48.80M shares derived: average of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | 50.79M shares 10-Q · filed 2025-08-14 | 50.68M shares 10-Q · filed 2025-08-14 | 48.12M shares derived: average of 3 quarters · filed 2025-08-14 | 46.71M shares derived: average of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 50.57M shares 10-Q · filed 2025-05-01 | 46.79M shares derived: average of 2 quarters · filed 2025-05-01 | 45.35M shares derived: average of 3 quarters · filed 2025-05-01 | 44.63M shares derived: average of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | 43.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 42.75M shares derived: average of 2 quarters · filed 2025-03-27 | 42.65M shares derived: average of 3 quarters · filed 2025-03-27 | 42.60M shares 10-K · filed 2025-03-27 |
| 2023-09-30 | 42.48M shares 10-Q · filed 2024-11-14 | 42.47M shares derived: average of 2 quarters · filed 2024-11-14 | 42.46M shares 10-Q · filed 2024-11-14 | 42.44M shares derived: average of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | 42.47M shares 10-Q · filed 2024-08-01 | 42.45M shares 10-Q · filed 2024-08-01 | 42.43M shares derived: average of 3 quarters · filed 2024-08-01 | 42.42M shares derived: average of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | 42.44M shares 10-Q · filed 2024-05-02 | 42.41M shares derived: average of 2 quarters · filed 2024-05-02 | 42.41M shares derived: average of 3 quarters · filed 2024-05-02 | 42.40M shares derived: average of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | 42.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 42.39M shares derived: average of 2 quarters · filed 2024-02-29 | 42.39M shares derived: average of 3 quarters · filed 2024-02-29 | 42.38M shares 10-K · filed 2024-02-29 |
| 2022-09-30 | 42.39M shares 10-Q · filed 2023-11-09 | 42.38M shares derived: average of 2 quarters · filed 2023-11-09 | 42.37M shares 10-Q · filed 2023-11-09 | 42.35M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 42.38M shares 10-Q · filed 2023-08-10 | 42.37M shares 10-Q · filed 2023-08-10 | 42.34M shares derived: average of 3 quarters · filed 2023-08-10 | 42.30M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 42.36M shares 10-Q · filed 2023-05-09 | 42.32M shares derived: average of 2 quarters · filed 2023-05-09 | 42.27M shares derived: average of 3 quarters · filed 2023-05-09 | 42.18M shares derived: average of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | 42.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 42.22M shares derived: average of 2 quarters · filed 2023-02-23 | 42.12M shares derived: average of 3 quarters · filed 2023-02-23 | 42.03M shares 10-K · filed 2023-02-23 |
| 2021-09-30 | 42.16M shares 10-Q · filed 2022-11-09 | 42.03M shares derived: average of 2 quarters · filed 2022-11-09 | 41.95M shares 10-Q · filed 2022-11-09 | 41.22M shares derived: average of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | 41.91M shares 10-Q · filed 2022-08-11 | 41.84M shares 10-Q · filed 2022-08-11 | 40.91M shares derived: average of 3 quarters · filed 2022-08-11 | 32.61M shares derived: average of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | 41.77M shares 10-Q · filed 2022-05-12 | 40.42M shares derived: average of 2 quarters · filed 2022-05-12 | 29.51M shares derived: average of 3 quarters · filed 2022-05-12 | 24.04M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | 39.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 23.38M shares derived: average of 2 quarters · filed 2022-03-15 | 18.13M shares derived: average of 3 quarters · filed 2022-03-15 | 15.51M shares 10-K · filed 2022-03-15 |
| 2020-09-30 | 7.70M shares 10-Q · filed 2021-11-09 | 7.67M shares derived: average of 2 quarters · filed 2021-11-09 | 7.66M shares 10-Q · filed 2021-11-09 | |
| 2020-06-30 | 7.65M shares 10-Q · filed 2021-08-12 | 7.63M shares 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |